Exploring Novel Vitamin K Derivatives with Anti-SARS-CoV‑2 Activity

• Taiki Homma,
• Mika Okamoto,
• Ryohto Koharazawa,
• Mayu Hayakawa,
• Taiki Fushimi,
• Chisato Tode,
• Yoshihisa Hirota,
• Naomi Osakabe,
• Masanori Baba,
• Yoshitomo Suhara

Affiliations

Taiki Homma

Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan

Mika Okamoto

Division of Infection Control Research, Center for Advanced Science Research and Promotion, Kagoshima University, Kagoshima, Japan

Ryohto Koharazawa

Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan

Mayu Hayakawa

Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan

Taiki Fushimi

Functional Control Systems, Graduate School of Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan

Chisato Tode

Instrumental Analysis Center, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan

Yoshihisa Hirota

Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan

Naomi Osakabe

Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan

Masanori Baba

Division of Infection Control Research, Center for Advanced Science Research and Promotion, Kagoshima University, Kagoshima, Japan

Yoshitomo Suhara

Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Minuma-ku, Saitama, Japan